Viewing Study NCT04239833


Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2025-12-31 @ 2:10 PM
Study NCT ID: NCT04239833
Status: UNKNOWN
Last Update Posted: 2020-01-27
First Post: 2020-01-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of SH-1028 Tablets Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-01-31
Start Date Type: ESTIMATED
Primary Completion Date: 2022-01-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-01-31
Completion Date Type: ESTIMATED
First Submit Date: 2020-01-02
First Submit QC Date: None
Study First Post Date: 2020-01-27
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-01-20
Last Update Post Date: 2020-01-27
Last Update Post Date Type: ACTUAL